Literature DB >> 20016084

Transplanted neural precursors enhance host brain-derived myelin regeneration.

Ofira Einstein1, Yael Friedman-Levi, Nikolaos Grigoriadis, Tamir Ben-Hur.   

Abstract

In multiple sclerosis lesions resident oligodendrocyte progenitor cells (OPCs) are present, but fail to remyelinate. In the current study we examined whether neural precursor cell (NPC) transplantation can facilitate host brain-derived remyelination. We used the chronic cuprizone-induced demyelination model in aged mice, in which slow remyelination follows cuprizone removal. NPCs were transplanted to the lateral ventricles (intracerebroventricular) of cuprizone-induced demyelinated brains. In this experimental setup, transplanted cells remained mostly in the periventricular area in an undifferentiated state. The extent of demyelination, remyelination, and proliferation of host brain regenerative cell population were examined at 1 week posttransplantation in the splenium of the corpus callosum, which was devoid of any transplanted cells. Transplantation of NPCs, but not of control, human embryonic kidney cells, significantly enhanced remyelination compared with sham-operated mice. Remyelination was performed exclusively by host brain OPCs. The proregenerative effect of transplanted NPCs was related to an increase in the proliferation of host brain OPCs. To examine the mechanism that underlies the proregenerative effect of NPCs in vitro, we used an NPC-OPC coculture system. These experiments indicated that NPCs induced the proliferation of OPCs and facilitated their differentiation into mature oligodendrocytes. The mitogenic effect of NPCs was mediated by platelet-derived growth factor-AA and fibroblast growth factor-2. In conclusion, NPC transplantation enhances host-derived myelin regeneration following chronic demyelination. This trophic effect may stimulate resident OPCs to overcome the remyelination failure in multiple sclerosis.

Entities:  

Mesh:

Year:  2009        PMID: 20016084      PMCID: PMC6666185          DOI: 10.1523/JNEUROSCI.3364-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

1.  Intravenous administration of human embryonic stem cell-derived neural precursor cells attenuates cuprizone-induced central nervous system (CNS) demyelination.

Authors:  S J Crocker; R Bajpai; C S Moore; R F Frausto; G D Brown; R R Pagarigan; J L Whitton; A V Terskikh
Journal:  Neuropathol Appl Neurobiol       Date:  2011-10       Impact factor: 8.090

Review 2.  Stem cells for brain repair in neonatal hypoxia-ischemia.

Authors:  L Chicha; T Smith; R Guzman
Journal:  Childs Nerv Syst       Date:  2013-11-01       Impact factor: 1.475

Review 3.  PET molecular imaging in stem cell therapy for neurological diseases.

Authors:  Jiachuan Wang; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-23       Impact factor: 9.236

Review 4.  Current challenges for the advancement of neural stem cell biology and transplantation research.

Authors:  Kristien Reekmans; Jelle Praet; Jasmijn Daans; Veerle Reumers; Patrick Pauwels; Annemie Van der Linden; Zwi N Berneman; Peter Ponsaerts
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

5.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

Review 6.  Cell therapy for multiple sclerosis.

Authors:  Tamir Ben-Hur
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

7.  Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination.

Authors:  Lucia M Whitman; Caroline A Blanc; Chris S Schaumburg; David H Rowitch; Thomas E Lane
Journal:  Exp Neurol       Date:  2012-03-17       Impact factor: 5.330

8.  Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System.

Authors:  Stylianos Ravanidis; Kyriaki Nepheli Poulatsidou; Roza Lagoudaki; Olga Touloumi; Elena Polyzoidou; Athanasios Lourbopoulos; Evangelia Nousiopoulou; Paschalis Theotokis; Evangelia Kesidou; Dimitrios Tsalikakis; Dimitrios Karacostas; Maria Grigoriou; Katerina Chlichlia; Nikolaos Grigoriadis
Journal:  Stem Cells Transl Med       Date:  2015-10-28       Impact factor: 6.940

9.  Two-photon imaging of remyelination of spinal cord axons by engrafted neural precursor cells in a viral model of multiple sclerosis.

Authors:  Milton L Greenberg; Jason G Weinger; Melanie P Matheu; Kevin S Carbajal; Ian Parker; Wendy B Macklin; Thomas E Lane; Michael D Cahalan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

10.  A cord blood monocyte-derived cell therapy product accelerates brain remyelination.

Authors:  Arjun Saha; Susan Buntz; Paula Scotland; Li Xu; Pamela Noeldner; Sachit Patel; Amy Wollish; Aruni Gunaratne; Tracy Gentry; Jesse Troy; Glenn K Matsushima; Joanne Kurtzberg; Andrew E Balber
Journal:  JCI Insight       Date:  2016-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.